FIELD: medicine; pharmacy.
SUBSTANCE: invention relates to medicine and pharmacy and relates to a pharmaceutical composition of neuroprotective action in the form of a lyophilisate for the manufacture of injection or infusion dosage forms containing as an active ingredient hexamethylenediamine bis-(N-monosuccinyl-L-glutamyl-L-lysine) and lyoprotectants and cryoprotectants in a certain quantitative ratio of the components used as functional additives, when using the recommended modes of drying and freezing.
EFFECT: implementation of the invention allows to create a stable dosage form, optimal for storage and use, and also to receive the preparation providing increase in duration of a finding of a dipeptide in a system blood-groove in comparison with its substance.
5 cl, 4 tbl, 11 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL COMPOSITION OF NEUROPROTECTIVE ACTION FOR ORAL ADMINISTRATION BASED ON HEXAMETHYLENE AMIDE BIS-(N-MONOSUCCINYL-1-GLUTAMYL-L-LYSINE) (VERSIONS), MADE IN FORM OF A TABLET DISPERSIBLE IN THE ORAL CAVITY | 2018 |
|
RU2740754C1 |
| PHARMACEUTICAL COMPOSITION BASED ON BIS-(N-MONOSUCCINYL-L-SERYL-L-LYSINE) HEXAMETHYLENEDIAMIDE (GSB-106) | 2018 |
|
RU2697254C1 |
| SMALL MOLECULES WITH NGF-LIKE ACTIVITY AND ANTIDIABETIC PROPERTIES | 2013 |
|
RU2613314C2 |
| SUBSTANCE WITH ANGIOGENIC ACTIVITY | 2013 |
|
RU2613184C2 |
| HEPATOPROTECTIVE EFFECT OF LOW MOLECULAR WEIGHT MIMETICS NGF | 2022 |
|
RU2790828C1 |
| METHOD FOR PRODUCING PHARMACEUTICAL COMPOSITION BASED ON HEXAMETHYLENEDIAMIDE BIS-(N-MONOSUCINYL-L-SERYL-L-LYSINE) | 2021 |
|
RU2790827C1 |
| DIMERIC DIPEPTIDE MIMETICS OF NEUROTROFIN-3 | 2022 |
|
RU2800369C1 |
| DRUG PREPARATION WITH ANTIARRHYTHMIC AND ANTIFIBRILLATORY ACTION | 2010 |
|
RU2477144C2 |
| COMPOSITION FOR OPTICAL VISUALIZATION, METHOD OF ITS PRODUCTION AND USE | 2019 |
|
RU2802481C2 |
| SUBSTANCE WITH ANTI-ANGIOGENIC ACTIVITY | 2013 |
|
RU2625752C2 |
